Announce Date | 04/14/2025 |
EPS Normalized Actual | $14.12 (Beat by $1.8) |
EPS GAAP Actual | $14.12 (Beat by $1.8) |
Revenue Actual | $12.167B |
Revenue Surprise | Beat by $12167M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $9.8761 |
EPS GAAP Estimate | $9.8761 |
Revenue Estimate | $13.181729258B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 65.2 | 11.1 | 59.34024 | 72.23482 | 1 |
Dec 2028 | 60.5 | 11.96 | 57.05725 | 64.08387 | 6 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 14.25 | 14.25 | 12.167B | -164.32% | 12167M |
FQ4 2024 (Dec 2024) | 12.17 | 12.17 | 13.518B | 100% | 13518M |
FQ3 2024 (Sep 2024) | 8.56 | 8.56 | 31.524B | 62.51% | 31524M |
FQ2 2024 (Jun 2024) | 8.77 | 8.77 | 12.731B | 14.42% | 12731M |
FQ1 2024 (Mar 2024) | 12.31 | 12.31 | 32.16B | 61.99% | 32160M |
FQ4 2023 (Dec 2023) | 0 | 0 | 0B | -INF% | 0M |
FQ3 2023 (Sep 2023) | 5.52 | 5.52 | 11.817B | -1.34% | 11817M |
FQ2 2023 (Jun 2023) | 3.09 | 3.09 | 10.895B | -8.89% | 10895M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
9.8761
Consensus Revenue Estimates
13.181729258B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 12.85388 | -- | 11.90659 | 13.55183 | 4 |
FQ3 2027 (Sep 2027) | 12.902 | -- | 11.95116 | 13.60256 | 3 |
FQ2 2027 (Jun 2027) | 13.83971 | -- | 12.81977 | 14.59119 | 4 |
FQ1 2027 (Mar 2027) | 16.38805 | -- | 15.1803 | 17.2779 | 3 |
FQ4 2026 (Oct 2026) | 11.43188 | -- | 10.73623 | 12.19024 | 7 |
FQ3 2026 (Jul 2026) | 11.10204 | -- | 10.42646 | 11.83852 | 4 |
FQ2 2026 (Jun 2026) | 10.58271 | -- | 9.90632 | 11.13115 | 4 |
FQ1 2026 (Mar 2026) | 11.53914 | -23.49 | 10.80162 | 12.13715 | 4 |
FQ4 2025 (Oct 2025) | 10.10356 | -20.45 | 9.48874 | 10.7738 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 15.19B | -- | 14.33B | 15.83B | 3 |
FQ3 2027 (Sep 2027) | 14.94B | -- | 14.1B | 15.57B | 3 |
FQ2 2027 (Jun 2027) | 15.53B | -- | 14.65B | 16.18B | 3 |
FQ1 2027 (Mar 2027) | 16.9B | -- | 15.94B | 17.61B | 3 |
FQ4 2026 (Oct 2026) | 13.95B | -- | 13.3B | 14.66B | 5 |
FQ3 2026 (Jul 2026) | 14.18B | -- | 13.52B | 14.91B | 5 |
FQ2 2026 (Jun 2026) | 13.76B | -- | 13.08B | 14.31B | 6 |
FQ1 2026 (Mar 2026) | 14.42B | 15.62 | 13.71B | 14.99B | 4 |
FQ4 2025 (Oct 2025) | 13.23B | -2.2 | 12.61B | 13.9B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 14.25 | 14.25 | 100% | |
FQ4 2024 (Dec 2024) | 12.17 | 12.17 | 100% | |
FQ3 2024 (Sep 2024) | 8.56 | 8.56 | 100% | |
FQ2 2024 (Jun 2024) | 8.77 | 8.77 | 100% | |
FQ1 2024 (Mar 2024) | 12.31 | 12.31 | 100% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 5.52 | 5.52 | 100% | |
FQ2 2023 (Jun 2023) | 3.09 | 3.09 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $12.17B | $12167M | 100% |
FQ4 2024 (Dec 2024) | $0B | $13.52B | $13518M | 100% |
FQ3 2024 (Sep 2024) | $0B | $31.52B | $31524M | 100% |
FQ2 2024 (Jun 2024) | $0B | $12.73B | $12731M | 100% |
FQ1 2024 (Mar 2024) | $0B | $32.16B | $32160M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0B | $0M | NAN% |
FQ3 2023 (Sep 2023) | $0B | $11.82B | $11817M | 100% |
FQ2 2023 (Jun 2023) | $0B | $10.9B | $10895M | 100% |